image
Ardelyx, Inc. ARDX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.36
2.68 %
$ 1.28 B
Market Cap
-31.53
P/E
BALANCE SHEET
436 M ASSETS
46.43%
Growth Rates
1Year 46.43%
3Years 42.71%
5Years 10.90%
7Years 15.61%
10Years 14.41%
262 M LIABILITIES
100.72%
Growth Rates
1Year 100.72%
3Years 57.41%
5Years 29.12%
7Years 45.97%
10Years 17.41%
173 M EQUITY
3.88%
Growth Rates
1Year 3.88%
3Years 28.01%
5Years -1.48%
7Years 3.17%
10Years 11.06%
BALANCE SHEET DECOMPOSITION
Balance Sheet Ardelyx, Inc.
image
Current Assets 356 M
Cash & Short-Term Investments 250 M
Receivables 57.7 M
Other Current Assets 48.6 M
Non-Current Assets 79.3 M
Long-Term Investments 0
PP&E 3.88 M
Other Non-Current Assets 75.4 M
Current Liabilities 77.8 M
Accounts Payable 16 M
Short-Term Debt 1.56 M
Other Current Liabilities 60.3 M
Non-Current Liabilities 185 M
Long-Term Debt 152 M
Other Non-Current Liabilities 32.8 M

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 64.9 21.5 96.1 72.4 91.0 181.1 78.8 75.4 74.6 107.0 107.3 34.4 32.9
Short Term Investments 185.2 162.8 27.8 44.3 95.5 66.4 89.3 58.6 126.2 0 0 0 0
Receivables 57.7 22.0 7.7 0.5 0 0.8 5.1 10.8 0 0 2.6 6.4 3.1
Inventory 21.2 12.4 3.3 0 0 1 0 1 0 0 1 1 0
Other Current Assets 27.5 27.3 18.7 16.5 8.2 3.8 3.2 4.9 6.3 5.0 1.2 1.0 1.8
Total Current Assets 356.5 246.1 154.5 134.8 195.2 252.4 177.7 149.9 204.0 112.2 111.3 41.8 36.9
PP&E 3.9 6.6 10.5 15.1 4.2 7.4 5.6 8.0 9.0 4.7 2.1 0.5 0.8
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 2.1 0 0 0 0 100 K 0 0 0
Other Long Term Assets 75.4 44.9 25.1 0 0 0 0 0 0.1 100 K 0 0.5 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 435.8 297.6 190.1 149.9 201.6 259.8 183.3 157.9 213.1 116.9 113.4 42.9 37.9
LIABILITIES
Accounts Payable 16.0 11.1 10.9 4.3 5.6 2.2 1.1 3.9 5.6 2.8 3.1 2.3 1.1
Short Term Debt 1.6 4.4 34.5 39.2 8.4 6.4 0 0 0 0 0 0 0
Other Current Liabilities 49.6 27.6 16.0 9.3 10.2 9.1 15.6 13.9 13.6 4.9 2.4 1.0 1.7
Total Current Liabilities 77.8 50.4 74.6 57.5 28.4 22.2 17.7 17.9 19.2 7.7 5.6 17.1 16.8
Long Term Debt 151.9 51.5 5.9 9.7 47.0 50.9 49.2 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 32.8 20.2 11.3 0 0 0 0.6 0.7 0.8 0.3 0.1 6.6 3.2
Total Liabilities 262.5 130.8 91.7 67.3 75.5 73.1 67.5 18.6 20.0 8.0 52.7 50.2 39.1
EQUITY
Common Stock 24 K 23 K 20 K 13 K 9 K 9 K 6 K 5 K 5 K 3 K 2 K 0 0
Retained Earnings (885.3) (846.2) (780.1) (712.9) (554.8) (460.5) (365.5) (278.2) (213.9) (101.5) (71.9) (68.7) (62.1)
Other Accumulative Comprehensive Income/Loss 57 K 0.2 54 K 6 K 4 K 20 K 38 K 47 K 71 K (3.8) (3.6) (3.3) (2.7)
Total Equity 173.3 166.8 98.3 82.6 126.1 186.7 115.8 139.3 193.2 108.9 60.7 (7.3) (1.2)
Total Liabilities and Equity 435.8 297.6 190.1 149.9 201.6 259.8 183.3 157.9 213.1 116.9 113.4 42.9 37.9
SHARES OUTSTANDING
Common Shares Outstanding 235.2 219.3 158.7 104.2 89.6 64.5 56.2 47.4 40.1 22.9 10.2 13.3 13.3